Document is current

Article History

Received: 5 November 2024

Accepted: 28 January 2025

First Online: 2 March 2025

Declarations

:

: Carsten-Henning Ohlmann: received support for the present publication from Astellas; received payment or honoraria for lectures, presentations, speakers bureaus, publication writing or educational events from Astellas, Janssen-Cilag, and AstraZeneca; received payment for expert testimony from Janssen-Cilag; received support for attending meetings and/or travel from Bayer and Janssen-Cilag; and participated on a data safety monitoring board or advisory board of Bayer, Janssen-Cilag, and AstraZeneca. Axel S. Merseburger: received support for the present publication from Astellas; received payment or honoraria for lectures, presentations, speaker bureaus, publication writing, or educational events from Janssen, Astellas, and Bayer. He is an Editorial Board member of Advances in Therapy. He was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Armen Aprikian: received payment or honoraria for lectures, presentations, speaker bureaus, publication writing, or educational events; received support for attending meetings and/or travel from Tolmar and Tersera; and has leadership or fiduciary role in other board, society, committee, or advocacy group, paid or unpaid for Canadian Urology Association and Cedars Cancer Foundation. Alexis Serikoff: received support for the present publication from Astellas. Andrew Chilelli: received support for the present publication and attending meetings and/or travel from Astellas. Eugen Dornstauder: received support for the present publication from Astellas. Andrew Chilelli, Eugen Dornstauder, Matthias Stoelzel, Alexis Serikoff: full-time employees of Astellas Pharma. Sophia Junker: is an employee of Ingress-Health HWM GmbH, a Cytel Company that was contracted by Astellas Pharma Europe Ltd. to conduct this research. Philipp Hahn: is an employee of IPAM e.V. that was contracted by Cytel to conduct this research. Stefan G. Spitzer: has received support from Astellas as a consultant.

: Since this study was based on anonymized and nonidentifiable data, no informed consent or ethics approval from an institutional review board was required. The research followed legal and internal standard processes of database handlers that communicated only aggregated findings with the sponsor. Permission was obtained to access and use patient-level data from AOK PLUS and GWQ, in line with data protection concepts of relevant local regulations [].